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doi:10.1016/j.ejvs.2008.11.010Abstract Objectives: To find variables associated with outcome following thrombolytic
treatment for acute lower limb ischemia.
Design: Re-analysis of a prospective multicentre study.
Material and methods: One hundred and twenty-one patients with acute lower limb ischemia
previously included in a randomised study comparing high- with low-dose thrombolysis were
re-analysed ignoring the mode of lytic treatment. All possibly predictive variables were
subjected to multivariate analyses to find associations with outcome.
Results: Previous successful thrombolysis, ankleebrachial index over 0.33, absence of motor
dysfunction, presence of cardiac arrhythmia, and lysis of a vascular graft were all associated
with successful thrombolysis (pZ 0.003). Previous thrombolysis, age less than 70 years, and
ankleebrachial index over 0.33 were all perfect predictors of absence of life-threatening
complications or death. Successful lysis, age< 70, and lysis of a native artery as opposed to
a vascular graft were all associated with clinical success (preserved patency, limb, and life)
after one year (pZ 0.002).
Conclusions: Previous thrombolysis, age under 70 years, and non-severe ischemia predict
successful thrombolysis free from severe complications. Successful thrombolysis is strongly
predictive of amputation-free survival with vascular patency for at least one year. Occluded
grafts could often be reopened, but long-term outcome is better after thrombolysis of native
arteries.
ª 2008 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.061528; fax: þ46 424061593.
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ty for Vascular Surgery. PublisheIntroduction
Thrombolysis has been used in the treatment of acute lower
limb ischemia since the 1950s. Comparative analyses with
other modes of treatment, e.g. anticoagulation treatment
or surgical intervention, have produced conflicting
results.1,2 Various refinements of technical details andd by Elsevier Ltd. All rights reserved.
Table 1 Exclusion criteria
Major surgery< 10 days
Haematuria< 10 days













Thrombolysis for Acute Lower Limb Ischemia 207a better patient selection have improved the outcome with
all modes of treatment. Currently, thrombolytic treatment
is generally recommended for acute or semi-acute cases
without severe loss of sensory and motor function.3,4 Still,
failed lysis and early or late recurrences are common
despite adjunctive surgical and medical interventions.1,4e7
In addition, thrombolytic treatment is afflicted with risks of
adverse events mostly related to bleeding but also to
induced embolisation for instance from the heart. Hence,
the preferable choice of treatment very much depends on
expected success and risk of complications in the individual
patient.
Most previous attempts to predict the outcome of
thrombolytic treatment have consisted of retrospective
analyses of the degree of thrombolysis and of early clinical
results.8e14 Conclusions have been most variable depending
upon a great diversity in thrombolytic agents and tech-
niques used, definitions of radiological and clinical success,
duration of follow-up and also due to the low accuracy of
retrospective and univariate investigations usually
emploied.15
We have previously published a prospective, rando-
mised, multicentre study comparing two well-established
modes of thrombolysis (low-dose, end-hole infusion versus
high-dose, pulse-spray infusion).16 This study failed to
demonstrate a significant difference in outcome except for
a lower incidence of re-interventions with the latter tech-
nique. The present study is an initially planned continua-
tion of the previous investigation lumping the two
treatment groups together in order to identify variables
associated with successful or failed thrombolysis, severe
complications, or a satisfactory clinical outcome. We have
chosen not to include any analysis of mode of thrombolytic
technique in the present communication, since this was
extensively covered in the previous report.
Material and Methods
Setting
Four Swedish vascular centres at the county hospitals of
Eskilstuna, Helsingborg, Va¨stera˚s, and Va¨xjo¨ included the
patients in a prospective randomised study performed
during 1997e2000. The ethical committees of the Univer-
sities of Lund, Go¨teborg, Linko¨ping, and O¨rebro, Sweden
approved the study. The present, initially planned, re-
analysis of the same patient material was performed at
the Department of Surgery in Helsingborg in co-operation
with the Department of Statistics at Lund University,
Sweden.
Participants
One hundred and twenty-one patients with sudden onset of
lower limb ischemia within 30 days were included. Presumed
thrombotic and embolic occlusions of native arteries as well
as vascular grafts were accepted if the proximal occlusion
level was located distal to the aortic bifurcation. Patients
with contra-indications to thrombolysis, urgent need for
revascularisation, irreversible ischemia, and patients not
amenable to follow-up were excluded (Table 1). The presentstudy comprises a re-analysis of all included patients
ignoring the mode of thrombolysis initially employed. The
demographic and clinical data of the patients are presented
in Tables 2 and 3. The proximal occlusion level was located
in the iliac arteries in 17 patients (14%), femoral arteries in
83 patients (69%), and in the popliteal or crural arteries in 21
patients (17%).
Objectives
To find variables associated with successful or failed
thrombolysis, severe complications, as well as a good
clinical outcome up to one year after the initial event.
Interventions
The techniques of angiography and thrombolysis in the two
treatment groups are described in detail in the previous
report.16 The adjunctive medical treatment and interven-
tions provided are summarised in Table 4.
Outcomes
Successful thrombolysis was defined as removal of >75% of
the thrombus with re-establishment of an antegrade flow
through the previously occluded vascular segment as
demonstrated on the completion angiogram. Failed
thrombolysis was defined as removal of <25% of the
thrombus without re-establishment of an antegrade flow.
The remaining patients were considered to have partial
thrombolysis.
Life-threatening complications included all severe and
lethal complications occurring during the first month. In the
presence of multiple complications, only the underlying or
most important was registered. Minor bleedings were not
considered as life-threatening.
A successful clinical outcome was defined as an ampu-
tation-free survival combined with at least secondary
patency of the initially occluded vessel. This was analysed
at one month and one year after the initial event.
Table 2 Demographic data
Variable Number of patients
Age (mean; range) 72; 47e97
Female sex 58 (48%)
Smokinga 43 (36%)
Diabetes 20 (17%)
Heart disease 76 (63%)
Hypertension 43 (36%)
Cerebrovascular disease 23 (19%)
Hyperlipidaemiaa 16 (13%)
Previous ipsi-lateral surgery 51 (42%)
Previous ipsi-lateral thrombolysis 13 (11%)
Occluded vesselZ graft 35 (29%)
Occluded vesselZ native artery 86 (71%)
a Information missing in several patients.
Table 4 Adjunctive treatment
Treatment Number of patients
Medicala
Antiplatelet drugs 63 (61%)





Aneurysm exclusionc 2 (2%)
Endarterectomyd 1 (1%)
a Information missing in 17 patients.
b Percutaneous transluminal angioplasty.
c Popliteal aneurysms.
d Outflow in groin.
208 G. Plate et al.Statistical methods
Nineteen variables were considered potentially associated
with successful or failed thrombolysis (Table 5). Nine of
these were binary. Each of the other ten was dichotomised
in all possible ways selecting the dichotomisation that had
the best association to the evaluation variable (univariate
analysis, Fisher’s exact test). The 19 binary variables so
obtained were used in logistic regression with backward
elimination until all remaining variables had p-val-
ues< 0.05. The p-value of the final model can of course
not be taken at face value, the model being the result of
an extensive search among a large number of possible
models. This was compensated for with another statistical
method (permutation testing) to achieve a more reliable
evaluation. This was performed by randomly permuting
the values of the outcome variable among the patients,
then repeating the whole selection and analysis proce-
dure, and finally registering the p-value of the model so
obtained. This was repeated 1000 times. The p-value of
the permutation test is the fraction of repetitions that
resulted in a more ‘‘significant’’ model than did theTable 3 Clinical data
Variable Number of patients
Symptom:
claudication 18 (15%)
Rest pain 92 (76%)
Tissue loss 11 (9%)
Duration:
<1 day 29 (24%)
1e3 days 28 (23%)
4e7 days 32 (26%)
8e30 days 32 (26%)




ABIa median (range). 0.1 (0e0.8)
a Ankleebrachial index.analysis of the original data. The same statistical methods
were used for the analysis of life-threatening complica-
tions and for clinical outcome. Two variables, degree of




Information on the degree of lysis is missing in two patients
in whom a post-treatment angiogram was not obtained.
Successful thrombolysis (>75% of the thrombus removed
combined with antegrade flow) was accomplished in 86/119
patients (72%). Seventeen of 119 patients (14%) had partial
thrombolysis and in 16/119 patients (13%) the thrombolysis
failed (<25% lysis without antegrade flow).
Fifteen patients (12%) experienced life-threatening
complications within one month (Table 6). Only two of
them survived. The clinical outcomes after one month and
one year are presented in Table 7.
Logistic regression (Table 8)
Degree of lysis
Previously performed thrombolysis was a perfect predictor
of another successful thrombolysis. That is, all 13 patients
who had previously received thrombolysis had a successful
thrombolysis this time also. This variable and these 13
patients were then excluded from further analysis of pre-
dicting the degree of lysis.
Four other variables were highly predictive of successful
thrombolysis: Ankleebrachial index> 0.33, no loss of motor
function, presence of cardiac arrhythmia, and target ves-
selZ occluded vascular graft (as opposed to a native
artery). Permutation testing of this model revealed a
p-valueZ 0.003.
Logistic regression for analysis of failed thrombolysis
revealed only one variable with a p-value< 0.05 (loss of
motor function). The permutation testing of this model
gave a p-valueZ 0.25.














Limb coldness (proximal level)
Loss of sensation (severity)
Loss of motor function (severity)
Proximal level of occlusion
Occluded vessel (graft or native artery)
Guide-wire passage through thrombus
Post-treatment prophylaxisa
Degree of lysisa
a For analysis of life-threatening complications and clinical
outcome.
Table 6 Life-threatening complications (one month)





a Urosepsis and peritonitis, respectively.
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Previously performed thrombolysis, age less than 70 years,
and ankleebrachial index over 0.33 were all three perfect
predictors of absence of life-threatening complications or
death. The 61 patients who had either of these character-
istics were then excluded from further analysis. The
multivariate analysis of the remaining 60 patients disclosed
only loss of motor function as predictive of life-threatening
complications. The permutation testing of this model had
a p-value> 0.06.
Clinical success at one month
Five variables were highly predictive of a successful clinical
outcome at one month: degree of lysis> 75%, age< 70
years, claudication or rest pain without ulcer or gangrene,
limb coldness only below the knee, and no previous
vascular operation. Permutation testing of this model
revealed a p-value< 0.001.
Clinical success at one year
Three variables were highly predictive of a successful
clinical outcome at one year: degree of lysis> 75%,
age< 70 years, and occluded vesselZ native vessel (as
opposed to a vascular graft). The permutation testing of
this model had a p-valueZ 0.002.
Discussion
It is obvious that the outcome of thrombolytic treatment
very much depends on the efficacy of the treatment, i.e.
the ability to reopen the occluded vessel.1 Supporting this,
we recorded that successful thrombolysis correlated to
clinical success for at least one year. It is therefore not
surprising that many previous reports have focused onfactors associated with the immediate success of throm-
bolysis. As in our study, radiological success has usually
been defined as removal of 70e95% of the thrombus
material with creation of an antegrade flow of blood in the
previously occluded graft or vascular segment. Associations
with such radiological success have been recorded for
location and extension of the occlusions, for vascular run-
off, for duration and severity of the ischemia, and for
several other variables.4,10,12,17 Some investigations have
failed to find any parameters predicting successful throm-
bolysis.8,13,18 Most reports consist of a univariate analysis of
a retrospectively collected material, which is generally
considered as less reliable.15 We have found only four
studies19e22 that include a multivariate analysis of variables
considered possibly predictive of success or failure with
thrombolytic treatment.
In 1994, Clouse et al.19 retrospectively analysed 82
patients treated with high-dose urokinase combined with
angioplasty (11%) or surgery (47%). Their end point was
a combination of radiological (antegrade flow) and clinical
(clearance of symptoms for 30 days) success. They found
only two variables (bad vascular run-off and presence of
coronary artery disease) that possibly predicted outcome,
basically clinical failure. This small study seems less
conclusive mainly because of its retrospective nature.
In the same year, Ouriel et al.20 reported on both uni-
and multivariate analyses of predictors for clot dissolution
using catheter-directed urokinase thrombolysis. As expec-
ted, the outcome of the univariate analysis differed from
the multivariate analysis. Diabetes, catheter passage into
the thrombus, guide-wire traversal through the thrombus
(positive guide-wire test), number of segments throm-
bosed, and type of conduit maintained associations with
the degree of lysis following multivariate analysis. Their
results differ from ours, the reason for which is not obvious.
Their inclusion criteria, thrombolytic agents used, study
design, and statistical methods were slightly different,
whereas the end points seem to have been similar.
Earnshaw et al.21 reported clinical factors associated
with early outcome from a large national audit of throm-
bolysis for acute leg ischemia (NATALI). A total of 1133
thrombolytic events were included making this study most
reliable. They started with univariate analysis and per-
formed the multivariate analysis only on those variables
that were significant. The main end point was amputation-
free survival after 30 days. They found that a low ampu-
tation-free survival was associated with diabetes,
increasing age, short-duration and severe ischemia. This
fairly well agrees with our recorded predictors of early
clinical success, except for thrombolytic outcome that
was not included in their predictor analysis. They still
Table 7 Outcome
Outcome 1 month 1 year
Failure 16/119 (13%) 16/119 (13%)
Re-occlusion 16 (13%) 30 (25%)
Re-intervention 24a (20%) 36b (30%)
Secondary patency 83/108 (77%) 65/95 (65%)
Amputation 7 (6%) 15 (12%)
Death 13 (11%) 26 (21%)
Amputation-free survival 103 (85%) 84 (69%)
Clinical successc 83 (69%) 61 (50%)
Number of patients (%).
a 30 procedures.
b 50 procedures.
c Amputation-free survival with at least secondary patency of
target vessel.
210 G. Plate et al.considered that the best predictor of outcome is whether
the procedure is successful or not. In a secondary analysis,
they recorded female sex, ischemic heart disease, native
vessel occlusion, and embolism as predictive of early
death. This differs from our predictors of life-threatening
complication. The reason for this is not clear, but the
definitions of this end point were not the same.
In a most recent report, Kuoppala et al.22 retrospec-
tively analysed prognostic factors for long-term clinical
outcome (median follow-up of 32 months) in 195 consec-
utive patients treated with thrombolysis for acute as well
as non-acute limb ischemia. Multivariate analysis, which
was only performed in factors with significant outcome in
the initial univariate analysis, revealed degree of lysis,Table 8 Results, logistic regression
Outcome Predictive varia
Successful thrombolysisa Previous lysis
Ankleebrachial
No loss of moto
Cardiac arrhyth
Occluded vesse
Failed thrombolysisb Loss of motor f
Absence of life-threatening complication Previous lysis
Age< 70 years
Ankleebrachial
No loss of moto





Clinical success,e one year Degree of lysis
Age< 70 years
Occluded vesse
a >75% of the thrombus with re-establishment of antegrade flow.
b <25% of the thrombus without re-establishment of antegrade flow
c Perfect: all patients with this predictive variable had the noted o
d Patients with perfectly predicted outcome excluded.
e Amputation-free survival with target vessel patency.severity of ischemia, presence of foot ulcers, and ischemic
heart disease as predictive of amputation. Presence of
cardiac, renal, or cerebrovascular disease, foot ulcers,
and acute ischemia predicted early or late death. It is not
surprising that these results differ a great deal from our
findings, since their study design, inclusion criteria,
statistical methods, and end points were quite different.
It is noteworthy from their study, that long-term survival
seemed more related to co-morbidity, whereas limb
salvage was more related to severity of ischemia and to
therapeutic success. This agrees with the findings in the
NATALI-study.21
McNamara and Fischer23 already in 1985 recorded that
thrombolytic treatment had a much greater chance of
success when a guide-wire could be passed through the
thrombus (positive guide-wire test). This finding was later
corroborated by the multivariate analysis performed by
Ouriel et al.20 who recorded a better chance of success also
when placement of the thrombolysis catheter into the
thrombus was possible. In our study, we did not include
patients in whom the catheter could not be passed into the
thrombus but accepted patients with a negative guide-wire
test. Our univariate analysis, which is not presented due to
its inferior reliability, demonstrated a trend towards better
lysis with a positive guide-wire test. Successful thrombol-
ysis was achieved in 80% versus 63% (pZ 0.053, Fisher’s
exact test). This association was not verified with the
multivariate analysis. We now consider catheter placement
within the thrombus as essential and a positive guide-wire
test as indicative for successful thrombolysis. This conclu-
sion is supported by the standards of practice presented by
Rajan et al.4bles Odds ratio Permutation test
Perfectc








r function 21.5d n.s.
grene 38.6 p< 0.001
> 75% 19.9
8.11
nly below knee 11.4
cular surgery 8.89
> 75% 8.95 pZ 0.002
4.37
lZ native artery 4.78
.
utcome.
Thrombolysis for Acute Lower Limb Ischemia 211Gender and age do not seem to have a significant influ-
ence on the initial outcome of thrombolytic treatment.19e22
In our study, age was a strong predictor of clinical success
free of complications, however (Table 8). This is supported
by the large NATALI-study21 and several other reports,7,19,20
while Kuoppala et al.22 did not find any association between
increasing age and long-term clinical outcome.
We did not find any association between smoking habits
and the early or intermediate outcome of thrombolytic
treatment. Smoking habits were not either recorded as
predictive of outcome in any of the four multivariate ana-
lyses.19e22 We have found only one report of smoking as
independently associated with failure of thrombolytic
treatment.1 Hence, no clear-cut conclusion can be drawn
regarding the influence of tobacco use on the outcome of
thrombolytic treatment.
From the Stile trial, Weaver et al.10 reported that dia-
betes was associated with a poor outcome following
thrombolytic treatment. Two multivariate analyses support
this concept.20,21 Our study did not reveal any association
between diabetes and outcome following thrombolytic
treatment. Also others have failed to find an association
between diabetes and successful thrombolysis.7,13,19
All our patients who had a history of previous (most
probably successful) thrombolytic treatment experienced
a successful lysis this time also. In comparison, thrombol-
ysis was successful in 69% of patients who had not been
treated with thrombolysis before. We have not found this
association in any other report.
Most authors10,19e22 have reported a strong correlation
between the severity of ischemia and clinical outcome with
thrombolytic treatment. Limb viability is especially
threatened in the presence of peripheral neurosensory
deficits. This agrees with our findings (Table 8). Many
patients with a greatly disturbed motor function are prob-
ably better treated with urgent surgical intervention. All
patients with irreversible ischemia are best treated with
primary amputation to decrease the risk of death.3,4
Palfreyman et al.2 performed a meta-analysis of rando-
mised trials comparing surgery with thrombolytic treat-
ment. Based on a sub-group analysis, they suggested better
outcome in patients treated with thrombolysis if the
duration of ischemia did not exceed 14 days. This basically
supports the concept that thrombolytic treatment should
be restricted to patients with acute ischemia.3,4 Only
dealing with acute cases, Earnshaw et al.21 found that
shorter duration of ischemia was associated with
a decreased amputation-free survival after 30 days. Kuop-
pola et al.22 and Korn et al.12 did not find any association
between outcome and the duration of acute ischemia. This
agrees with our findings. The reason for this discrepancy
regarding the influence of duration of ischemia is not clear.
Still, most authors agree that more chronic cases are less
suited for thrombolytic treatment.3,4,22
We recorded a greater chance for successful thrombol-
ysis in patients with cardiac arrhythmia, which could indi-
cate that emboli are better amenable for this treatment.
Unfortunately, the presence of atrial fibrillation, which is
a common cause for embolism, is generally considered as
a relative contra-indication to thrombolytic treatment due
to the risk of inducing more emboli. Actually, Earnshaw
et al.21 reported a higher mortality in patients withembolism. We could not confirm this in the present multi-
variate analysis, but two of our patients with chronic atrial
fibrillation died from ischemic stroke.16 It seems preferable
to perform surgical embolectomy in patients with presumed
embolism from the heart to the extremities.1e4
Although we did not analyse these variables, it is
reasonable to assume that the outcome of thrombolytic
treatment is dependent on the extension of thrombotic
involvement and on the quality of vascular run-off. This
concept is corroborated by several studies.17e20 DeMaior-
ibus et al.,8 Weaver et al.,10 and Korn et al.12 recorded
better outcomes for lysis of more proximal occlusions as
compared to distal occlusions. No such association was
recorded in the thorough radiographic analysis performed
by Braithwaite et al.,18 in none of the multivariate ana-
lyses,19e22 or by us. It is therefore likely that more exten-
sive thromboses and a bad run-off make thrombolytic
treatment less successful whereas thrombus location has
less impact on outcome.
Palfreyman et al.2 demonstrated better outcomes
following thrombolysis of graft occlusions as compared to
native artery occlusions. Ouriel et al.20 were more
successful with initial lysis of prosthetic grafts and native
arteries as opposed to vein grafts. Clouse et al.,19 Earn-
shaw et al.21 and Swischuk et al.13 did not find any
significant differences in early results related to type of
conduit. Contrary to their study, we noted significantly
better thrombolytic success with prosthetic as well as
venous grafts. Still, 66% of our native arteries were
successfully thrombolysed. Many authors have observed
that although vascular graft occlusions could be success-
fully reopened with thrombolysis, the recurrence rate is
high, the need for additional procedures is great, and long-
term patency is poor, especially with prosthetic graf-
ts.7,9,11,14,24e26 This was confirmed in our study, in which
patient with native artery occlusions had a better one-year
clinical outcome than those with occluded vascular grafts
(Table 8).
In conclusion, previous thrombolysis, age less than 70
years, and non-severe ischemia predict initially successful
thrombolysis free from complications. Successful throm-
bolysis and age under 70 years are in turn strongly associ-
ated with clinical success. Catheter placement within the
thrombus is essential, but a negative guide-wire test does
not preclude successful lysis. Occluded vascular grafts
could often be reopened, but long-term outcome is better
after thrombolysis of native arteries. Sex and smoking
habits barely affect outcome and neither did we find any
obvious associations with co-morbidity.
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